Immunomodulatory effects of antifungal agents on the response of human monocytic cells to Aspergillus fumigatus conidia

References

• Labro MT. Antibacterial agents-phagocytes: new concepts for old in immunomodulation. Int J Antimicrob Agents 1998; 10: 11–21.
   PubMed Web of Science ®Google Scholar
• Labro MT. Interference of antibacterial agents with phagocyte functions: immunomodulation or “immuno-fairy tales”? Clin Microbiol Rev 2000; 13: 615–650.
   PubMed Web of Science ®Google Scholar
• Shalit I, Kletter Y, Halperin D, . Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide induced leukopenia. Eur J Haematol 2001; 66: 287–296.
   PubMed Web of Science ®Google Scholar
• Jun YT, Kim HJ, Song MJ, . In vitro effects of ciprofloxacin and roxithromycin on apoptosis of Jurkat T lymphocytes. Antimicrob Agents Chemother 2003; 47: 1161–1164.
   PubMed Web of Science ®Google Scholar
• Khan AA, Slifer TR, Remington JS. Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob Agents Chemother 1998; 42: 1713–1717.
   PubMed Web of Science ®Google Scholar
• Riesbeck K, Forsgren A, Henriksson A, Bredberg A. Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes. Antimicrob Agents Chemother 1998; 42: 1923–1930.
   PubMed Web of Science ®Google Scholar
• Tohru K, Koichi H, Yoshihiro H, . Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kB transcription factors. J Antimicrob Chemother 2002; 49: 745–755.
   Google Scholar
• Simitsopoulou M, Roilides E, Paliogianni F, . Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors. Antimicrob Agents Chemother 2008; 52: 3301–3306.
   PubMed Web of Science ®Google Scholar
• Hohl TM, Feldmesser M, Perlin DS, Pamer EG. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis 2008; 198: 176–185.
   PubMed Web of Science ®Google Scholar
• Lamaris GA, Lewis RE, Chamilos G, . Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis 2008; 198: 186–192.
   PubMed Web of Science ®Google Scholar
• Stevens DA. Combination immunotherapy and antifungal chemotherapy. Clin Infect Dis 1998; 26: 1266–1269.
   PubMed Web of Science ®Google Scholar
• Choi JH, Song MJ, Kim SH, . Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells. Antimicrob Agents Chemother 2003; 47: 3704–3707.
   PubMed Web of Science ®Google Scholar
• Kwon EY, Park CM, Park SH, . Effects of antifungal agents on the production of cytokines from macrophages stimulated by Aspergillus fumigatus conidia. Infect Chemother 2007; 39: 38–45.
   Google Scholar
• Choi JH, Brummer E, Kang YJ, Jones PP, Stevens DA. Inhibitor kB and nuclear factor kB in granulocyte and macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia. J Infect Dis 2006; 193: 1023–1028.
   PubMed Web of Science ®Google Scholar
• Stevens DA. Th1/Th2 in aspergillosis. Med Mycol 2006; 44: S229–235.
   Web of Science ®Google Scholar
• Yano T, Teruya K, Shirahata S, . Ras oncogene enhances the production of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells. Cytotechnology 1994; 16: 167–178.
   Google Scholar
• Kim JY, Ro JY. Signal pathway of cytokines produced by reactive oxygen species generated from phorbol myristate actetate-stimulated HMC-1 cells. Scand J Immunol 2005; 62: 25–35.
   Google Scholar
• Rex JH, Stevens DA. Systemic antifungal agents. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Disease, 6th. Philadelphia: Churchill and Livingstone, 2005: ch. 37.
   Google Scholar
• Gartner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 2005; 24: 1277–1286.
   PubMed Web of Science ®Google Scholar
• Stevens DA. A possible mechanism for synergy between antifungal therapy and immune defense. J Infect Dis 2008; 198: 159–162.
   PubMed Web of Science ®Google Scholar
• Rivera A, Van Epps HL, Hohl TM, Rizzuto G, Pamer EG. Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia. Infect Immun 2005; 73: 7170–7179.
   PubMed Web of Science ®Google Scholar
• Sau K, Mambula SS, Latz E, . The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem 2003; 278: 37561–37568.
   PubMed Web of Science ®Google Scholar
• Razonable RR, Henault M, Lee LN, . Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of Toll-like receptor 1 and 2. Antimicrob Agents Chemother 2005; 49: 1617–1621.
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Iwasaki H, Uzui H, Ueda T. Candin family antifungal agent micafungin (FK463) modulates the inflammatory cytokine production stimulated by lipopolysaccharide in THP-1 cells. Transl Res 2006; 148: 207–213.
   PubMed Web of Science ®Google Scholar
• Marr KA, Balajee SA, Hawn TR, . Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun 2003; 71: 5280–5286.
   PubMed Web of Science ®Google Scholar
• Netea MG, Van der Graaf C, Van der Meer JWM, Kullberg BJ. Recognition of fungal pathogens by Toll-like receptors. Eur J Clin Microbiol Infect Dis 2004; 23: 672–676.
   PubMed Web of Science ®Google Scholar
• Bellocchio S, Montagnoli C, Bozza S, . The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059–3069.
   PubMed Web of Science ®Google Scholar
• Braedel S, Radsak M, Einsele H, . Aspergillus fumigatus antigens activate innate immune cells via Toll-like receptor 2 and 4. Br J Haematol 2004; 125: 392–399.
   PubMed Web of Science ®Google Scholar
• Brummer E, Maqbool A, Stevens DA. Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia. Med Mycol 2001; 39: 509–515.
   PubMed Web of Science ®Google Scholar